Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.

[1]  A. Weyrich,et al.  Comment on Chapter 5 , 1999 .

[2]  T. Bodmer,et al.  Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis , 2009, Journal of perinatal medicine.

[3]  P. Hatton,et al.  In vitro activity of an aqueous allicin extract and a novel allicin topical gel formulation against Lancefield group B streptococci. , 2008, The Journal of antimicrobial chemotherapy.

[4]  S. Schrag,et al.  Trends in perinatal group B streptococcal disease - United States, 2000-2006. , 2009, MMWR. Morbidity and mortality weekly report.

[5]  I. Margarit,et al.  Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. , 2009, The Journal of infectious diseases.

[6]  M. Edwards Group B streptococcal conjugate vaccine: A timely concept for which the time has come , 2008, Human vaccines.

[7]  P. Trieu-Cuot,et al.  Invasive Group B Streptococcal Infections in Infants, France , 2008, Emerging infectious diseases.

[8]  W. Schaffner,et al.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. , 2008, JAMA.

[9]  J. Sever,et al.  Group B Streptococcus and pregnancy: a review. , 2008, American journal of obstetrics and gynecology.

[10]  R. Baltimore,et al.  Changing Patterns in Neonatal Escherichia coli Sepsis and Ampicillin Resistance in the Era of Intrapartum Antibiotic Prophylaxis , 2008, Pediatrics.

[11]  V. Ganesh,et al.  Duration of Antimicrobial Prophylaxis for Group B Streptococcus in Patients With Preterm Premature Rupture of Membranes Who Are Not in Labor , 2008 .

[12]  Tiffany S. Glasgow,et al.  Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers. , 2007, Paediatric and perinatal epidemiology.

[13]  T. Noakes,et al.  Semmelweis and the aetiology of puerperal sepsis 160 years on: an historical review , 2007, Epidemiology and Infection.

[14]  N. Ragni,et al.  The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study , 2007, Archives of Gynecology and Obstetrics.

[15]  R. Rappuoli,et al.  Group B Streptococcus: global incidence and vaccine development , 2006, Nature Reviews Microbiology.

[16]  Claudio Donati,et al.  Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. , 2006, Current opinion in microbiology.

[17]  A. Schuchat,et al.  Risk Factors for Invasive, Early-Onset Escherichia coli Infections in the Era of Widespread Intrapartum Antibiotic Use , 2006, Pediatrics.

[18]  G. Natarajan,et al.  Real-Time Polymerase Chain Reaction for the Rapid Detection of Group B Streptococcal Colonization in Neonates , 2006, Pediatrics.

[19]  H. Leu,et al.  Group B streptococcal bacteremia in non-pregnant adults. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[20]  C. Baker,et al.  Prospects for prevention of childhood infections by maternal immunization , 2006, Current opinion in infectious diseases.

[21]  H. Jörnvall,et al.  Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions , 2005, Cellular and Molecular Life Sciences CMLS.

[22]  C. Baker,et al.  Group B streptococcal infections in elderly adults. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  B. Stoll,et al.  Very Low Birth Weight Preterm Infants With Early Onset Neonatal Sepsis: The Predominance of Gram-Negative Infections Continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003 , 2005, The Pediatric infectious disease journal.

[24]  M. Weinstein,et al.  The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. , 2005, Vaccine.

[25]  E. Eichenwald,et al.  Early-Onset Group B Streptococcal Disease in the Era of Maternal Screening , 2005, Pediatrics.

[26]  E. Lieberman,et al.  No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. , 2005, American journal of obstetrics and gynecology.

[27]  C. Baker,et al.  Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  J. M. Koenig,et al.  Neonatal Neutrophils with Prolonged Survival Exhibit Enhanced Inflammatory and Cytotoxic Responsiveness , 2005, Pediatric Research.

[29]  Vincent A. Fischetti,et al.  Removal of Group B Streptococci Colonizing the Vagina and Oropharynx of Mice with a Bacteriophage Lytic Enzyme , 2005, Antimicrobial Agents and Chemotherapy.

[30]  D. Laskin,et al.  Mechanisms Underlying Reduced Apoptosis in Neonatal Neutrophils , 2005, Pediatric Research.

[31]  M. Battin,et al.  Escherichia coli: a growing problem in early onset neonatal sepsis , 2004, The Australian & New Zealand journal of obstetrics & gynaecology.

[32]  M. Bergeron,et al.  Laboratory detection of group B Streptococcus for prevention of perinatal disease , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[33]  A. Schuchat,et al.  Trends in Sepsis-Related Neonatal Mortality in the United States, 1985–1998 , 2004, The Pediatric infectious disease journal.

[34]  V. Nizet,et al.  Extracellular virulence factors of group B Streptococci. , 2004, Frontiers in bioscience : a journal and virtual library.

[35]  A. Alarcon,et al.  Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis , 2004, The Pediatric infectious disease journal.

[36]  D. Kasper,et al.  Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. , 2004, The Journal of infectious diseases.

[37]  M. Yoder,et al.  Neonatal neutrophils: the good, the bad, and the ugly. , 2004, Clinics in perinatology.

[38]  W. Keitel,et al.  Healthy Elderly People Lack Neutrophil‐Mediated Functional Activity to Type V Group B Streptococcus , 2004, Journal of the American Geriatrics Society.

[39]  R. Rappuoli,et al.  New Generation Vaccines, 3rd Edition , 2004 .

[40]  L. Paoletti,et al.  Oxygen Regulates Invasiveness and Virulence of Group B Streptococcus , 2003, Infection and Immunity.

[41]  C. Baker,et al.  Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. , 2003, Vaccine.

[42]  M. Pearlman Prevention of early-onset group B streptococcal disease in newborns. , 2003, Obstetrics and gynecology.

[43]  Stephanie Schrag,et al.  Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC , 2002 .

[44]  K. O'Brien,et al.  Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. , 2002, Pediatrics.

[45]  C. Baker CDC revises group B strep prevention guidelines , 2002 .

[46]  G. Sanders,et al.  Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. , 2002, Pediatrics.

[47]  W. Poole,et al.  Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. , 2002, The New England journal of medicine.

[48]  A. Baxter Louis Pasteur's beer of revenge , 2001, Nature Reviews Immunology.

[49]  S. Kenyon,et al.  Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial , 2001, The Lancet.

[50]  D. Kasper,et al.  Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. , 2000, The Journal of infectious diseases.

[51]  R. Platt,et al.  Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  A. Schuchat,et al.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.

[53]  R. Rappuoli Reverse vaccinology : Genomics , 2000 .

[54]  J. Hadler,et al.  From the Centers for Disease Control and Prevention: early-onset group B streptococcal disease--United States, 1998-1999. , 2000, JAMA.

[55]  P. Ferrieri,et al.  Changing Epidemiology of Group B Streptococcal Colonization , 1999, Pediatrics.

[56]  R. Platt,et al.  Resource utilization associated with initial hospital stays complicated by early onset group B streptococcal disease. , 1999, The Pediatric infectious disease journal.

[57]  T. Raju Ignác Semmelweis and the Etiology of Fetal and Neonatal Sepsis , 1999, Journal of Perinatology.

[58]  D. Kasper,et al.  Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. , 1999, The Journal of infectious diseases.

[59]  G. Escobar,et al.  Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics , 1999, Pediatrics.

[60]  A. Schuchat Group B streptococcus , 1999, The Lancet.

[61]  D. Kasper,et al.  Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. , 1999, The Journal of infectious diseases.

[62]  J. M. Koenig,et al.  Spontaneous and Fas‐mediated apoptosis are diminished in umbilical cord blood neutrophils compared with adult neutrophils , 1998, Journal of leukocyte biology.

[63]  A. Schuchat Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.

[64]  J. Schollin,et al.  Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates , 1998, Archives of disease in childhood. Fetal and neonatal edition.

[65]  L. Wright,et al.  Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. , 1997, Pediatrics.

[66]  C. Baker,et al.  Group B streptococcal infections. , 1997, Clinics in perinatology.

[67]  J. Tyson,et al.  Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. , 1996, The Journal of pediatrics.

[68]  A. Schuchat,et al.  Prevention of perinatal group B streptococcal disease : a public health perspective , 1996 .

[69]  A. Spitzer,et al.  Intensive Care Of The Fetus And Neonate , 1996 .

[70]  R. Gibson,et al.  Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells , 1995, Infection and immunity.

[71]  K. Tullus,et al.  Correlation between susceptibility of infants to infections and interaction with neutrophils of Escherichia coli strains causing neonatal and infantile septicemia. , 1995, The Journal of infectious diseases.

[72]  C. Rubens,et al.  Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components , 1994, Infection and immunity.

[73]  F. Noya,et al.  Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci , 1993, Infection and immunity.

[74]  C. Baker,et al.  Fibronectin levels in premature infants with late-onset sepsis. , 1993, Journal of perinatology : official journal of the California Perinatal Association.

[75]  C. Broome,et al.  American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. , 1992, Pediatrics.

[76]  J. Campbell,et al.  Deposition and degradation of C3 on type III group B streptococci , 1991, Infection and immunity.

[77]  S. Garland,et al.  Group B Streptococcus (GBS) and Neonatal Infections: The Case for Intrapartum Chemoprophylaxis , 1991, The Australian & New Zealand journal of obstetrics & gynaecology.

[78]  H. Hill,et al.  Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. , 1991, The Journal of pediatrics.

[79]  R. Matorras,et al.  Maternal colonization by group B streptococci and puerperal infection; analysis of intrapartum chemoprophylaxis. , 1991, European journal of obstetrics, gynecology, and reproductive biology.

[80]  Gary J. Nabel,et al.  New Generation Vaccines , 1990 .

[81]  V. Nizet,et al.  Chapter 13 – Group B Streptococcal Infections , 1990 .

[82]  D. Anderson,et al.  Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. , 1990, The Journal of infectious diseases.

[83]  M. Berger Complement deficiency and neutrophil dysfunction as risk factors for bacterial infection in newborns and the role of granulocyte transfusion in therapy. , 1990, Reviews of infectious diseases.

[84]  Quie Pg Antimicrobial defenses in the neonate. , 1990 .

[85]  Anderson Dc Neonatal neutrophil dysfunction. , 1992 .

[86]  M. Hallman,et al.  Prevention of Neonatal Group B Streptococcal Disease: Intrapartum Detection and Chemoprophylaxis of Heavily Colonized Parturients , 1989, Obstetrics and gynecology.

[87]  C. Baker,et al.  Fibronectin and age-limited susceptibility to type III, group B Streptococcus. , 1988, The Journal of infectious diseases.

[88]  C. Baker,et al.  Type III group B Streptococcus: functional interaction with IgG subclass antibodies. , 1987, The Journal of infectious diseases.

[89]  K. Boyer,et al.  Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis , 1986, The New England journal of medicine.

[90]  R. Feigin,et al.  Textbook of Pediatric Infectious Diseases , 1986 .

[91]  I. Loudon Deaths in childbed from the eighteenth century to 1935. , 1986, Medical History.

[92]  C. Wilson,et al.  Immunologic basis for increased susceptibility of the neonate to infection. , 1986, The Journal of pediatrics.

[93]  A. Forsgren,et al.  Group B streptococci at delivery: high count in urine increases risk for neonatal colonization. , 1986, Scandinavian journal of infectious diseases.

[94]  D. Kasper,et al.  Group B streptococcal vaccines. , 1985, Reviews of infectious diseases.

[95]  H. Hill,et al.  Fatal early onset Group B streptococcal sepsis with normal leukocyte counts , 1985, Pediatric infectious disease.

[96]  A. Forsgren,et al.  Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. , 1985, Scandinavian journal of infectious diseases.

[97]  D. Kasper,et al.  The role of complement in opsonization of GBS. , 1985, Antibiotics and chemotherapy.

[98]  R. Polin,et al.  Diminished Bactericidal Capacity for Group B Streptococcus in Neutrophils from “Stressed” and Healthy Neonates , 1984, Pediatric Research.

[99]  K. Boyer,et al.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. , 1983, The Journal of infectious diseases.

[100]  K. Boyer,et al.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. , 1983, The Journal of infectious diseases.

[101]  J. Klein,et al.  Infectious Diseases of the Fetus and Newborn Infant , 1983 .

[102]  C. Baker,et al.  Impaired Chemotaxigenesis by Type III Group B Streptococci in Neonatal Sera: Relationship to Diminished Concentration of Specific Anticapsular Antibody and Abnormalities of Serum Complement , 1983, Pediatric Research.

[103]  D. Kasper,et al.  Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. , 1982, Journal of immunology.

[104]  D. Kasper,et al.  Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. , 1981, Pediatrics.

[105]  H. Dillon,et al.  A prospective study of group B streptococcal bacteriuria in pregnancy. , 1981, American journal of obstetrics and gynecology.

[106]  H. Hill,et al.  Defective oxidative metabolic responses of neutrophils from stressed neonates. , 1981, The Journal of pediatrics.

[107]  C. Baker,et al.  Group B streptococcal infections , 1999 .

[108]  R. Christensen,et al.  Exhaustion of mature marrow neutrophils in neonates with sepsis. , 1980, The Journal of pediatrics.

[109]  H. Hill,et al.  Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates. , 1979, The Journal of pediatrics.

[110]  E. Mason,et al.  Ampicillin prevents intrapartum transmission of group B streptococcus. , 1979, JAMA.

[111]  B. Curfman,et al.  Experimental group B streptococcal infection in the rhesus monkey. I. Disease production in the neonate. , 1978, American journal of obstetrics and gynecology.

[112]  F. Barrett,et al.  Group B streptococcal infections in infants. The importance of the various serotypes. , 1974, JAMA.

[113]  F. Barrett,et al.  Transmission of group B streptococci among parturient women and their neonates. , 1973, The Journal of pediatrics.

[114]  R. Facklam,et al.  Distribution by Serological Type of Group B Streptococci Isolated from a Variety of Clinical Material over a Five-Year Period (with Special Reference to Neonatal Sepsis and Meningitis) , 1973, Infection and immunity.

[115]  R. Feigin,et al.  Group B beta hemolytic streptococcal meningitis in infants. , 1973, The Journal of pediatrics.

[116]  M. Finland,et al.  NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI. , 1964, The New England journal of medicine.

[117]  George W. Dameron,et al.  Beta hemolytic streptococcus group B associated with problems of the perinatal period. , 1961, American journal of obstetrics and gynecology.

[118]  R. Fry FATAL INFECTIONS BY HÆMOLYTIC STREPTOCOCCUS GROUP B , 1938 .

[119]  R. Lancefield,et al.  THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN , 1935, The Journal of experimental medicine.

[120]  Pasteur ON THE GERM THEORY. , 1881, Science.